New and Emerging Treatments in Cutaneous Vasculitis

Cleveland Clinic Rheumatology

C. Langford

Checkpoint Inhibitors and Rheumatic Disease

NYU Langone

A. Bass

EADV 2023 Insights: Infectious Granulomatous Skin Diseases

EADV 2023 Insights

E. Laffitte

When Should Biologic Agents be Considered in Eosinophilic Granulomat…

Cleveland Clinic Rheumatology

M. Wechsler

EGPA: Challenges and Prognosis

Cleveland Clinic Rheumatology

R. Hajj-Ali

Could EGPA be Treated with Biologics?

Cleveland Clinic Rheumatology

M. Wechsler

Lupus And a New FDA Approval for EGPA

RheumNow

J. Cush

Eosinophilic Granulomatosis with Polyangiitis with Persistent Shortn…

Cleveland Clinic Rheumatology

A. Villa-Forte

EULAR 2023 Insights: Benralizumab for Eosinophilic Granulomatosis wi…

EULAR 2023 Insights

A. Bettiol

EGPA: Look Carefully at the Heart

Cleveland Clinic Rheumatology

W. Tang

Eosinophilic Granulomatosis with Polyangiitis

Hospital for Special Surgery

A. Dua

A Case of Acute Headache And Multifocal Strokes Leading to Diagnosis…

The Illinois Society of Allergy, Asthma, and Immunology Fall Conference 2024

A. Hua

Are There Factors That Can Guide Treatment Decisions in Newly Diagno…

Cleveland Clinic Rheumatology

A. Villa-Forte

ACR Convergence 2024 Highlights: Diagnosis of Giant Cell Arteritis b…

Highlights from ACR Convergence 2024

V. Caceres

Pathergy in Patients with Bechet's Disease Receiving Laser Hair Remo…

Evidence-Based Hair

J. Donovan

Great Debate (PMR/GCA) - Upfront Use of IL-6 Inhibitors

Hospital for Special Surgery

R. Spiera, P. Seo

Behçet Syndrome Diagnosis: How and When Do Major/Minor Clinical Mani…

Haner Direskeneli

Giant Cell Arteritis in the Arab Region With a Focus on Jordan

Fatima Al Naimat

Behcet Syndrome Update: How Does It Manifest? When Do Symptoms Typic…

Yusuf Yazici

Abstract Discussions: Osteoporotic Fractures in Postmenopausal Women…

RheumNow

J. Pope